国际眼科纵览 ›› 2014, Vol. 38 ›› Issue (2): 129-133.doi: 10.3706/ cma. j. issn.1673.5803.2014.02.011

• 综述 • 上一篇    下一篇

视网膜中央静脉阻塞的治疗现状

刘仁义  袁玲  袁援生   

  1. 650032 昆明医科大学第一附属医院眼科
  • 收稿日期:2013-10-10 出版日期:2014-04-25 发布日期:2014-05-01
  • 通讯作者: 袁玲,Email:yuanling8061@163.com
  • 基金资助:

    云南省教育厅昆明医科大学校级教研教改项目(2011JY1)

Treatment of central retinal vein occlusion

 LIU  Ren-Yi, YUAN  Ling, YUAN  Yuan-Sheng   

  1. Department of Ophthalmology, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China
  • Received:2013-10-10 Online:2014-04-25 Published:2014-05-01
  • Contact: YUAN Ling, Email: yuanling8061@163.com

摘要: 视网膜中央静脉阻塞是仅次于糖尿病性视网膜病变的常见视网膜血管病,常导致视力下降甚至失明,以往视网膜激光光凝术、手术、玻璃体腔注药等疗法对视网膜中央静脉阻塞的治疗有一定疗效,近年来一些新方法如抗新生血管内皮生长因子、地塞米松缓释剂以及联合治疗等的出现,取得较好效果,但更安全有效的治疗措施有待进一步研究。(国际眼科纵览,2014, 38: 129-133)

Abstract: Central retinal vein occlusion (CRVO)is a common retinal vascular disorder second to the diabetic retinopathy with potentially blinding complications. In the past, the vitrectomy surgery, laser photocoagulation, intravitreal injection and other therapies were used for the treatment of CRVO, and brought some effects. In recently,the emergence of some new methods, such as antineovascular endothelial growth factor, ozurdex etc. These methods achieved good effects. However,the specific curative therapies should be studied further. (Int Rev Ophthalmol, 2014, 38: 129-133)